Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | BL0175 |
Synonyms | |
Therapy Description |
Limited information is currently available on BL0175, a putative nanoconjugate drug delivering an estrogen receptor inhibitor (Dec 2024). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
BL0175 | Hormone - Anti-estrogens 31 | Limited information is currently available on BL0175, a putative nanoconjugate drug delivering an estrogen receptor inhibitor (Dec 2024). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT06738966 | Phase I | BL0175 | A Study of BL0175 Injection in Postmenopausal Female Adults with HR-positive, Locally Advanced or Metastatic Cancer | Not yet recruiting | AUS | 0 |